I agree it could be something to look into. Nano delivery of vaccines. They have to be careful not to just jump on the bandwaggon of a news worthy issue. The H1N1 could have been a non issue if it hit earlier and simply was added to the regular vaccine.
I remember when Linux was the next big thing in computing. Many tech companies would find an angle to use linux in their company and get an interview on BNN. The stock would pop and then nothing. I like what ALRX has in thier product pipeline. All I was saying is let one of their lead products make it to Phase III. The industry will take note and they will have more options open up to them for investors and product.
